Works by Oya, Mototsugu

Results: 384
    1
    2
    3
    4

    Adjuvant nivolumab versus placebo following radical surgery for high-risk muscle-invasive urothelial carcinoma: a subgroup analysis of Japanese patients enrolled in the phase 3 CheckMate 274 trial.

    Published in:
    Japanese Journal of Clinical Oncology, 2023, v. 53, n. 1, p. 16, doi. 10.1093/jjco/hyac155
    By:
    • Tomita, Yoshihiko;
    • Kobayashi, Ko;
    • Kimura, Go;
    • Oya, Mototsugu;
    • Uemura, Hirotsugu;
    • Nishiyama, Hiroyuki;
    • Galsky, Matthew D;
    • Nasroulah, Federico;
    • Collette, Sandra;
    • Broughton, Edward;
    • Ünsal-Kaçmaz, Keziban;
    • Kamisuki, Yukinori;
    • Bajorin, Dean F
    Publication type:
    Article
    5
    6

    Erratum to: Subgroup analysis of the AFTER I-O study: a retrospective study on the efficacy and safety of subsequent molecular targeted therapy after immune-oncology therapy in Japanese patients with metastatic renal cell carcinoma.

    Published in:
    Japanese Journal of Clinical Oncology, 2021, v. 51, n. 12, p. 1770, doi. 10.1093/jjco/hyab161
    By:
    • Tomita, Yoshihiko;
    • Kimura, Go;
    • Fukasawa, Satoshi;
    • Numakura, Kazuyuki;
    • Sugiyama, Yutaka;
    • Yamana, Kazutoshi;
    • Naito, Sei;
    • Kaneko, Hirokazu;
    • Tajima, Yohei;
    • Oya, Mototsugu
    Publication type:
    Article
    7

    Subgroup analysis of the AFTER I-O study: a retrospective study on the efficacy and safety of subsequent molecular targeted therapy after immune-oncology therapy in Japanese patients with metastatic renal cell carcinoma.

    Published in:
    Japanese Journal of Clinical Oncology, 2021, v. 51, n. 11, p. 1656, doi. 10.1093/jjco/hyab114
    By:
    • Tomita, Yoshihiko;
    • Kimura, Go;
    • Fukasawa, Satoshi;
    • Numakura, Kazuyuki;
    • Sugiyama, Yutaka;
    • Yamana, Kazutoshi;
    • Naito, Sei;
    • Kaneko, Hirokazu;
    • Tajima, Yohei;
    • Oya, Mototsugu
    Publication type:
    Article
    8
    9
    10
    11
    12

    Difficulty in differential diagnosis for renal cancer with microscopic papillary architecture: overlapped pathological features among papillary renal cell carcinoma (RCC), mutinous tubular and spindle cell carcinoma, and unclassified RCC. Lessons from a Japanese multicenter study

    Published in:
    Japanese Journal of Clinical Oncology, 2020, v. 50, n. 11, p. 1313, doi. 10.1093/jjco/hyaa114
    By:
    • Ito, Keiichi;
    • Mikami, Shuji;
    • Kuroda, Naoto;
    • Nagashima, Yoji;
    • Tatsugami, Katsunori;
    • Masumori, Naoya;
    • Kondo, Tsunenori;
    • Takagi, Toshio;
    • Nakanishi, Shotaro;
    • Eto, Masatoshi;
    • Kamba, Tomomi;
    • Tomita, Yoshihiko;
    • Matsuyama, Hideyasu;
    • Tsushima, Tomoyasu;
    • Nakazawa, Hayakazu;
    • Oya, Mototsugu;
    • Kimura, Go;
    • Shinohara, Nobuo;
    • Asano, Tomohiko
    Publication type:
    Article
    13
    14
    15
    16
    17
    18

    Impact of inflammatory marker levels one month after the first-line targeted therapy initiation on progression-free survival prediction in patients with metastatic clear cell renal cell carcinoma.

    Published in:
    Japanese Journal of Clinical Oncology, 2019, v. 49, n. 1, p. 69, doi. 10.1093/jjco/hyy154
    By:
    • Ito, Keiichi;
    • Masunaga, Ayako;
    • Tanaka, Nobuyuki;
    • Mizuno, Ryuichi;
    • Shirotake, Suguru;
    • Yasumizu, Yota;
    • Ito, Yujiro;
    • Miyazaki, Yasumasa;
    • Hagiwara, Masayuki;
    • Kanao, Kent;
    • Mikami, Shuji;
    • Momma, Tetsuo;
    • Masuda, Takeshi;
    • Nakagawa, Ken;
    • Oyama, Masafumi;
    • Asano, Tomohiko;
    • Oya, Mototsugu
    Publication type:
    Article
    19
    20
    21
    22
    23
    24

    Patient age was an independent predictor of cancer-specific survival in male patients with upper tract urothelial carcinoma treated by radical nephroureterectomy.

    Published in:
    Japanese Journal of Clinical Oncology, 2016, v. 46, n. 6, p. 554, doi. 10.1093/jjco/hyw028
    By:
    • Hiroaki Kobayashi;
    • Eiji Kikuchi;
    • Nobuyuki Tanaka;
    • Suguru Shirotake;
    • Yasumasa Miyazaki;
    • Hiroki Ide;
    • Jun Obata;
    • Katsura Hoshino;
    • Kazuhiro Matsumoto;
    • Gou Kaneko;
    • Masayuki Hagiwara;
    • Takeo Kosaka;
    • Masafumi Oyama;
    • Yosuke Nakajima;
    • Mototsugu Oya
    Publication type:
    Article
    25

    A large-scale prospective registration study of the safety and efficacy of sorafenib tosylate in unresectable ormetastatic renal cell carcinoma in Japan: results of over 3200 consecutive cases in post-marketing all-patient surveillance.

    Published in:
    Japanese Journal of Clinical Oncology, 2015, v. 45, n. 10, p. 953, doi. 10.1093/jjco/hyv099
    By:
    • Hideyuki Akaza;
    • Mototsugu Oya;
    • Masafumi Iijima;
    • Ichinosuke Hyodo;
    • Akihiko Gemma;
    • Hiroshi Itoh;
    • Masatoshi Adachi;
    • Yutaka Okayama;
    • Toshiyuki Sunaya;
    • Lyo Inuyama
    Publication type:
    Article
    26
    27

    Clinical efficacy and prognostic factors of tumor progression in Japanese patients with advanced renal cell carcinoma treated with sorafenib.

    Published in:
    Japanese Journal of Clinical Oncology, 2015, v. 45, n. 3, p. 274, doi. 10.1093/jjco/hyu200
    By:
    • Kondo, Tsunenori;
    • Nakazawa, Hayakazu;
    • Oya, Mototsugu;
    • Kimura, Go;
    • Fujii, Yasuhisa;
    • Hatano, Takashi;
    • Kawata, Nozomu;
    • Kume, Haruki;
    • Morita, Masashi;
    • Nakajima, Koichi;
    • Ohno, Yoshio;
    • Okegawa, Takatsugu;
    • Takahashi, Shunji;
    • Wakumoto, Yoshiaki;
    • Horie, Shigeo
    Publication type:
    Article
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39

    Contrast-enhanced Ultrasonography of the Prostate with Sonazoid.

    Published in:
    Japanese Journal of Clinical Oncology, 2010, v. 40, n. 11, p. 1099, doi. 10.1093/jjco/hyq102
    By:
    • Matsumoto, Kazuhiro;
    • Nakagawa, Ken;
    • Hashiguchi, Akinori;
    • Kono, Hidaka;
    • Kikuchi, Eiji;
    • Nagata, Hirohiko;
    • Miyajima, Akira;
    • Oya, Mototsugu
    Publication type:
    Article
    40

    Kidney Cancer Working Group Report.

    Published in:
    Japanese Journal of Clinical Oncology, 2010, v. 40, n. suppl_1, p. i51, doi. 10.1093/jjco/hyq127
    By:
    • Naito, Seiji;
    • Tomita, Yoshihiko;
    • Rha, Sun Young;
    • Uemura, Hirotsugu;
    • Oya, Mototsugu;
    • Song, He Zhi;
    • Zhong, Li Han;
    • Wahid, Mohamed Ibrahim Bin A
    Publication type:
    Article
    41
    42
    43
    44
    45
    46
    47

    BCG‐induced cytokine release in bladder cancer cells is regulated by Ca<sup>2+</sup> signaling.

    Published in:
    Molecular Oncology, 2019, v. 13, n. 2, p. 202, doi. 10.1002/1878-0261.12397
    By:
    • Ibarra, Cristián;
    • Karlsson, Marie;
    • Codeluppi, Simone;
    • Varas‐Godoy, Manuel;
    • Zhang, Songbai;
    • Louhivuori, Lauri;
    • Mangsbo, Sara;
    • Hosseini, Arad;
    • Soltani, Navid;
    • Kaba, Rahim;
    • Kalle Lundgren, T.;
    • Hosseini, Abolfazl;
    • Tanaka, Nobuyuki;
    • Oya, Mototsugu;
    • Wiklund, Peter;
    • Miyakawa, Ayako;
    • Uhlén, Per
    Publication type:
    Article
    48
    49
    50